Cat.#: ACPP-1262
| Despition | CXCR4 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1297 | p75 NGF Receptor Blocking Peptide (AC1297) | 250 µg | inquiry |
| ACPP-1180 | Native Human Luteinizing Hormone (Functional) (AC1180) | 100 µg | inquiry |
| ACPP-1791 | Human Thyroid Stimulating Hormone Receptor (Active) Protein (AC1791) | 100 µg | inquiry |
| ACPP-1032 | Recombinant Human PGRPS Protein (6×His Tag) (AC1032) | 50 µg | inquiry |
| ACPP-1254 | Luteinizing Hormone Blocking Peptide (AC1254) | 250 µg | inquiry |
| ACPP-1244 | SOX2 Blocking Peptide (AC1244) | 250 µg | inquiry |
| ACPP-1462 | Human CD34 Protein (AC1462) | 5 µg | inquiry |
| ACPP-1312 | Human GDNF Protein (AC1312) | 2 µg | inquiry |
| ACPP-1124 | Recombinant Human MAP2C Protein (AC1124) | 25 µl | inquiry |
| ACPP-1242 | MC3 Receptor Blocking Peptide (AC1242) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.